Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex in thyroid surgery
ChiCTR2000030083Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Feb 2020
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Sugammadex in thyroid neoplasm (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: K time, R time and 3 more. Started Feb 2020; status: recruiting.
02
Drugs
Sugammadex
03
Conditions
thyroid neoplasm
Beyond the preview
Go deeper on ChiCTR2000030083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030083.